Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04929912

Electroporation for Cancer Treatment Real World Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Mirai Medical · Industry
Sex
All
Age
Healthy volunteers

Summary

This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.

Conditions

Timeline

Start date
2021-06-24
Primary completion
2026-12-24
Completion
2036-06-24
First posted
2021-06-18
Last updated
2025-01-29

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04929912. Inclusion in this directory is not an endorsement.

Electroporation for Cancer Treatment Real World Registry (NCT04929912) · Clinical Trials Directory